Benzinga's Top #PreMarket Losers

Analogic

shares dropped 11.20% to $85.75 in pre-market trading after the company reported downbeat Q2 earnings. NewLink Genetics

shares fell 7.14% to $35.00 in the pre-market trading after the company's independent review committee recommended the study continuation without modification after completion of first interim analysis of IMPRESS Phase 3 pancreatic cancer trial with algenpantucel-L. FireEye

dipped 6.71% to $83.54 after the company priced its follow-on public offering of 14 million shares at $82.00 per share. The Gap

dipped 3.64% to $40.75 in the pre-market session after the company reported a 7% drop in its February same-store sales. However, analysts were expecting a 1.1% rise in same-store sales.